Molar pregnancy in the General Hospital of Riobamba. January 2013-March 2018
DOI:
https://doi.org/10.37135/ee.004.05.06Keywords:
Hydatidiform Mole, Gestational Trophoblastic Disease, Chorionic GonadotropinAbstract
Gestational trophoblastic disease is characterized by an abnormal growth of these cells of the placenta after abnormal fertilization; which may present alterations of premalignant and malignant type. A study with a mixed approach, descriptive, cross-sectional observational type, allowed to reach the purpose of describing the incidence of molar pregnancy in patients attended in the General Hospital of Riobamba, during the period January 2013- March 2018. The universe of study was constituted by the clinical histories of the pregnant women attended in the Service of Gynecology and Obstetrics of that institution of health mentioned above. 53 records of patients with an accurate diagnosis of molar pregnancy were chosen by an intentional or deliberate non-probabilistic sampling. 66% of the patients under study were in the range of 10 to 19.6 weeks at the time of being diagnosed with hydatidiform mole. There was a high incidence of pathology between the 16 to 25 years of ages with 64%. The most frequent symptomatology reported included vaginal bleeding and abdominal pain with a total of 92.45%. However, benign entities predominated with 81.13%. The main risk factor of suffering this pathology was the antecedent of previous abortions.
Downloads
References
Santaballa A, García Y, Fuentes J, Herrero A, Laínez N, De Juan A, et al. SEOM clinical guidelines in gestational trophoblastic disease. Clinical and Translational Oncology [Internet]. 2017 [citado: 2018 Mayo 02]; 20(1): 38-46. Disponible en:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/.
Cabero Roura L, Saldivar Rodriguez D. Operatoria Obstétrica.Una visión actual [Internet]. Primera ed. México: Médica Panamericana; 2009 [citado: 2018 Mayo 03]. Disponible en: https://books.google.com.ec/books?id=n7qU5f6W9qIC&printsec=frontcover&hl=es#v=onepage&q&f=false.
Durón González R, Bolaños Morera P. Enfermedad trofoblástica gestacional. Medicina Legal de Costa Rica [Internet]. 2018 [citado: 2018 Mayo 05]; 35(1): 30-43. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152018000100030&lng=en&tlng=pt.
Stevens FT, Katzorke N, Tempfer C, Kreimer U, Bizjak GI, Fleisch MC & Fehm TN. Gestational Trophoblastic Disorders: An Update in 2015. Geburtshilfe Und Frauenheilkunde [Internet]. 2015 [citado: 2018 Mayo 07]; 75(10): 1043–50. Disponible en: doi:http://doi.org/10.1055/s-0035-1558054.
Cabrera Figueredo I, Valdivieso Y, Fonseca D, Amador de Varona D, Rodriguez D. Caracterización de la enfermedad trofoblástica gestacional en Camagüey [Internet]. 2014 [citado: 2018 Mayo 09]; 54(257): 25-35. Disponible en: http://www.rev16deabril.sld.cu/index.php/16_04/article/view/51.
Espinoza Cárdenas D, Beltrán Vidal L, Pozo Ocampo D. Caso Clínico: Mola Hidatiforme Parcial.Resolución Obstétrica. Revista Médica HJCA [Internet]. 2017 [citado 2018 Mayo 12]; 9(3): 291-295. Disponible en: doi:http://dx.doi.org/10.14410/2017.9.3.cc.47.
Fagnoni Bollo JC. Diagnóstico y tratamiento: Enfermedad trofoblástica gestacional. Arch GyO [Internet]. 2015 [citado: 2018 Mayo 16]; 53(3): 36-50. Disponible en: https://www.sguruguay.org/img/noticias/AGO%2053_3%20web.pdf.
Hernández-Flores SE, Vega-Memije ME, Niebla-Cárdenas D, Audifred Salomón JR, Hal Ramírez WB. Incidencia de enfermedad trofoblástica gestacional. Ginec Obst Mex [Internet]. 2016 [citado 2018 Mayo 20]; 84(6): 377-382. Disponible en: http://www.medigraphic.com/pdfs/ginobsmex/gom-2016/gom166g.pdf.
Arriagada DR, Novoa RR. Mola hidatidiforme completa con preeclampsia e hipertiroidismo: presentación clásica. Rev Chil OyG [Internet]. 2017 [citado 2018 Mayo 25]; 82(1): 77-79. Disponible en: doi:http://dx.doi.org/10.4067/S0717-75262017000100011.
Colón J, De Ponte A, Serrano R, Aponte A. Mola hidatiforme recurrente asociada a mutación del gen NLRP7: a propósito de un caso. Rev OyG Ven [Internet]. 2015 [citado: 2018 Junio 05]; 75(4): 280-283. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0048-77322015000400008&lng=es&tlng=es.
Bruce S, Sorosky J. Gestational Trophoblastic Disease. StatPearls [Internet]. 2017; [citado: 2018 Junio 02]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK470267/.
Calles-Ramírez E. Perfil epidemiológico, evolución clínica y complicaciones en pacientes con enfermedad gestacional del trofoblasto en el hospital nacional especializado de maternidad enero- diciembre 2013 [tesis de grado]. [San Salvador]: Universidad del Salvador; 2015.
Akinlaja O, McKendrick R, Mashak Z, Nokkaew M. Incidental Finding of Persistent Hydatidiform Mole in an Adolescent on Depo-Provera [Internet]. Epub 2016 Dic [citado 2018 Jun 05]. Disponible en: https://www.hindawi.com/journals/criog/2016/6075049/. http://dx.doi.org/10.1155/2016/6075049.
Agrawal N, Sagtani RA, Budhathoki SS, and Pokharel HP. Clinico-epidemiological profile of molar pregnancies in a tertiary care centre of Eastern Nepal: a retrospective review of medical récords. Gynecol Oncol Res Pract [Internet]. 2015 [citado 16 Dic 2017]; 2: 9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881004/. DOI: 10.1186/s40661-015-0017-y.
Vázquez Y, Brito A , Delgado L, Vázquez E. Caracterización clínica de la enfermedad trofoblástica gestacional en el Hospital ginecobstetrico Ramón Gonzales Coro. Rev Cubana Hig Epidemiol [Internet]. 2014 [citado 2018 Abr 13]; 52(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032014000200004).
Agustín A, Savirón R, Lerma D, Herrero A, Campillos JM. Coriocarcinoma postgestacional. Rev. chil. obstet. ginecol [Internet]. 2015 Ago [citado 2018 Jul 05]; 80(5): 405-411. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262015000500009&lng=es. http://dx.doi.org/10.4067/S0717-75262015000500009.
Santaballa A, García Y, Herrero A, Laínez N, Fuentes J, De Juan A, et al. SEOM clinical guidelines in gestational trophoblastic disease Published online 2017. Clin Transl Oncol [Internet]. 2018 [citado 23 May 2018]; 20(1): 38–46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785593/. DOI:10.1007/s12094-017-1793-0.
